Sep 2026
Investigating the anti-TNBC potential of new quinazoline-based PAK4 inhibitors: design, synthesis and biological evaluation.
Results validate 11j as a promising lead for TNBC therapy, especially in combination with EGFR-targeted agents.
Shuang Hao, Yi-Fan Niu, Meng Si et al.
· European journal of medicina... · 0 citations